Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Benefits System Contract Awarded To NDCHealth

This article was originally published in The Pink Sheet Daily

Executive Summary

Under the contract, NDCHealth will coordinate beneficiary coverage between prescription drug plans and entities other than Medicare. The one-year contact is valued at $416,700 with three one-year extensions; it also includes up to $3.9 mil. for processing transactions during a single year.

You may also be interested in...



Third-Party Coordination Of Medicare Rx Benefits Is Focus Of CMS Request

Centers for Medicare & Medicaid Services’ request for proposals seeks a contractor to assist in “coordinating benefits and facilitating an accurate accounting of a beneficiary’s true out-of-pocket spending,” Administrator McClellan tells Senate Special Committee on Aging.

Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic

Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.

User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles

A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles

Topics

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel